Mirizio · Regenerative therapy 2025 · narrative review · n=?

Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming.

Cited 4 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of molecular mechanisms and cellular biology with no clinical or experimental human trial data.

PubMed 39834592 · doi:10.1016/j.reth.2024.12.014 · record verified 2026-08-30

What was done

This paper provides a narrative review discussing the molecular mechanisms through which pioneer transcription factors (TFs) mediate cell fate conversions in induced pluripotent stem cell (iPSC) generation and direct somatic transdifferentiation. It focuses on the interplay between pioneer TFs and epigenetic modifiers, including Polycomb repressive complexes (PRCs), nucleosome remodeling and deacetylase (NuRD) complexes, and DNA methylation machinery.

What was found

The abstract reports no numerical data, quantitative comparisons, or statistical findings. It describes that pioneer TFs open chromatin to establish competence for new gene expression programs, while highlighting that many direct reprogramming processes remain inefficient.

Why it matters

Elucidating the interactions between pioneer TFs and chromatin-modifying complexes helps identify the mechanistic bottlenecks limiting somatic cell reprogramming efficiency, which is relevant for developing regenerative cell therapies.

Limits

As a narrative review, this work synthesizes existing mechanistic concepts rather than providing new primary empirical data or a systematic meta-analysis. No quantitative metrics or specific cell models are detailed in the abstract.

Cited by